(0.06%) 5 520.50 points
(0.11%) 39 886 points
(0.17%) 19 785 points
(0.00%) $81.63
(0.46%) $2.82
(-0.31%) $2 337.10
(0.03%) $29.54
(0.30%) $1 004.80
(0.02%) $0.932
(0.02%) $10.54
(0.01%) $0.788
(-0.85%) $87.25
1.75% $ 4.06
Live Chart Being Loaded With Signals
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company\'s discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics...
Stats | |
---|---|
Dzisiejszy wolumen | 807 673 |
Średni wolumen | 579 751 |
Kapitalizacja rynkowa | 475.53M |
EPS | $-0.190 ( Q1 | 2024-05-09 ) |
Następna data zysków | ( $-0.180 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-6.34 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00600 (0.15%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-18 | Love Steven | Buy | 20 000 | Restricted Stock Units |
2024-06-18 | Love Steven | Buy | 40 000 | Stock Option (right to buy) |
2024-06-18 | Higgins John L | Buy | 20 000 | Common Stock |
2024-06-18 | Higgins John L | Buy | 20 000 | Restricted Stock Units |
2024-06-18 | Higgins John L | Buy | 40 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
69.36 |
Last 99 transactions |
Buy: 7 848 926 | Sell: 800 922 |
Wolumen Korelacja
OmniAb, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OmniAb, Inc. Korelacja - Waluta/Towar
OmniAb, Inc. Finanse
Annual | 2023 |
Przychody: | $34.16M |
Zysk brutto: | $14.67M (42.93 %) |
EPS: | $-0.510 |
FY | 2023 |
Przychody: | $34.16M |
Zysk brutto: | $14.67M (42.93 %) |
EPS: | $-0.510 |
FY | 2022 |
Przychody: | $59.08M |
Zysk brutto: | $42.83M (72.49 %) |
EPS: | $-0.260 |
FY | 2021 |
Przychody: | $34.75M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.235 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
OmniAb, Inc.
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company\'s discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company\'s OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej